mesalamine has been researched along with Anemia, Megaloblastic in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Anemia, Megaloblastic: A disorder characterized by the presence of ANEMIA, abnormally large red blood cells (megalocytes or macrocytes), and MEGALOBLASTS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoshino, J | 1 |
| Sugawara, K | 1 |
| Ishikawa, S | 1 |
| Hayami, Y | 1 |
| Sakurazawa, T | 1 |
| Tanaka, T | 1 |
| Yamamoto, N | 1 |
| Hashimoto, M | 1 |
| Yamamoto, T | 1 |
| Hoshihara, Y | 1 |
1 review available for mesalamine and Anemia, Megaloblastic
| Article | Year |
|---|---|
[A case of ulcerative colitis with folate deficient megaloblastic anemia induced by sulfasalazine].
Topics: Adult; Anemia, Megaloblastic; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Folic Ac | 1999 |